RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: substance-induced psychosis
Accession: DOID:8646
browse the term
Definition: Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
Synonyms: exact_synonym: Drug Psychoses; Toxic Psychoses; substance-induced psychoses
primary_id: MESH:D011605 ; RDO:0006434
xref: ICD9CM:293.89
For additional species annotation, visit the
Alliance of Genome Resources .
G
Ace
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr11:105,967,948...105,989,964
Ensembl chr11:105,967,945...105,989,964
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr10:75,316,877...75,334,792
Ensembl chr10:75,316,877...75,334,784
G
Akt1
thymoma viral proto-oncogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr12:112,653,821...112,674,884
Ensembl chr12:112,653,821...112,674,884
G
Camk2b
calcium/calmodulin-dependent protein kinase II, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr11:5,969,629...6,066,357
Ensembl chr11:5,969,644...6,066,362
G
Esr1
estrogen receptor 1 (alpha)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr10:4,611,989...5,005,633
Ensembl chr10:4,611,593...5,005,614
G
Grm2
glutamate receptor, metabotropic 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 9:106,644,534...106,656,109
Ensembl chr 9:106,643,095...106,656,082
G
Gstp1
glutathione S-transferase, pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr19:4,035,411...4,037,912
Ensembl chr19:4,035,407...4,037,985
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr13:105,443,693...105,448,133
Ensembl chr13:105,443,639...105,448,122
G
Htr6
5-hydroxytryptamine (serotonin) receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 4:139,059,706...139,075,570
Ensembl chr 4:139,061,108...139,075,570
G
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 8:66,697,149...66,706,800
Ensembl chr 8:66,697,192...66,706,792
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr10:6,758,593...7,038,209
Ensembl chr10:6,758,506...7,038,198
G
Phb
prohibitin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr11:95,666,957...95,680,773
Ensembl chr11:95,666,957...95,680,773
G
Pick1
protein interacting with C kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr15:79,229,140...79,249,466
Ensembl chr15:79,229,173...79,249,484
G
Rgs9
regulator of G-protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr11:109,225,348...109,298,181
Ensembl chr11:109,225,355...109,298,129
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr13:73,536,128...73,578,672
Ensembl chr13:73,536,747...73,578,672
G
Snca
synuclein, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 6:60,731,573...60,829,855
Ensembl chr 6:60,731,575...60,829,855
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr17:13,007,839...13,018,119
Ensembl chr17:13,006,846...13,040,063
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr 5:121,566,027...121,593,824
Ensembl chr 5:121,566,027...121,593,824
G
Foxo4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:101,254,261...101,260,873
Ensembl chr X:101,254,528...101,260,873
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:33,653,238...33,698,162
Ensembl chr 8:33,652,523...33,698,163
G
Drd2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr 9:49,340,360...49,408,177
Ensembl chr 9:49,340,627...49,408,177
G
Ank3
ankyrin 3, epithelial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:69,533,486...70,027,436
Ensembl chr10:69,398,773...70,027,438
G
Apoe
apolipoprotein E
IMP
RGD
PMID:15007105
RGD:12904641
NCBI chr 7:19,696,244...19,701,310
Ensembl chr 7:19,696,109...19,699,188
G
Bpifa1
BPI fold containing family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr 2:154,142,880...154,149,217
Ensembl chr 2:154,142,880...154,149,219
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 2:103,453,904...103,485,153
Ensembl chr 2:103,453,849...103,485,160
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
treatment
ISO
RGD
PMID:22037411 , PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr 6:135,713,221...136,173,615
Ensembl chr 6:135,713,233...136,173,511
G
Igf1
insulin-like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr10:87,858,265...87,937,047
Ensembl chr10:87,858,265...87,937,042
G
Igf1r
insulin-like growth factor I receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 7:67,952,257...68,233,668
Ensembl chr 7:67,952,827...68,233,668
G
Nos1
nitric oxide synthase 1, neuronal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr 5:117,866,839...117,958,840
Ensembl chr 5:117,781,032...117,958,840
G
Pten
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr19:32,757,577...32,826,160
Ensembl chr19:32,757,497...32,826,160
G
Rps6ka1
ribosomal protein S6 kinase polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 4:133,847,290...133,887,797
Ensembl chr 4:133,847,290...133,887,797
G
Rhoa
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 9:108,306,160...108,337,943
Ensembl chr 9:108,306,129...108,337,934
G
Agtr1a
angiotensin II receptor, type 1a
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr13:30,336,356...30,382,867
Ensembl chr13:30,336,441...30,382,867
G
Agtr1b
angiotensin II receptor, type 1b
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr 3:20,314,473...20,367,177
Ensembl chr 3:20,314,473...20,367,177
G
Il1b
interleukin 1 beta
ISO
RGD
PMID:22959208
RGD:7204702
NCBI chr 2:129,364,569...129,371,164
Ensembl chr 2:129,364,570...129,371,139
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr 2:24,336,860...24,351,491
Ensembl chr 2:24,336,853...24,351,494
G
Ireb2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr 9:54,862,658...54,912,534
Ensembl chr 9:54,863,789...54,912,530
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all